Literature DB >> 15573057

Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods.

Abeer A Qadi1, Hala Tamim, Ghada Ameen, Abdulrahman Bu-Ali, Sameer Al-Arrayed, Naglaa A Fawaz, Wassim Y Almawi.   

Abstract

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections were assessed among 81 Bahraini and 34 Saudi hemodialysis patients and 7714 Bahraini and 2330 Saudi blood donors. Higher prevalence of HCV (9.24% vs 0.30%), hepatitis B surface antigen (5.88% vs 0.62%) were seen in patients versus control patients, and in Saudi patients compared with Bahraini patients. HCV genotypes were HCV 1a/1b plus HCV 4 among Bahraini patients and HCV 2/2a plus HCV 4 among Saudi patients. This is the first report on viral hepatitis in Bahrain and the first to compare HBV/HCV among dialysis patients in the Eastern Arabian Peninsula.

Entities:  

Mesh：

Year:  2004        PMID： 15573057     DOI： 10.1016/j.ajic.2003.12.009

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN： 0196-6553            Impact factor:   2.918


  14 in total

1.  Serological assay and genotyping of hepatitis C virus in infected patients in zanjan province.

Authors:  Abdolreza Esmaeilzadeh; Maryam Erfanmanesh; Sousan Ghasemi; Farzaneh Mohammadi
Journal:  Hepat Mon       Date:  2014-09-27       Impact factor: 0.660

Review 2.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 3.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 4.  Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis.

Authors:  Soheil Ashkani-Esfahani; Seyed Moayed Alavian; Mohammad Salehi-Marzijarani
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

Review 5.  Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Authors:  S Ramia; N M Melhem; K Kreidieh
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

6.  Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines.

Authors:  Andrew W Tu; Jane A Buxton; Mandy Whitlock; Ognjenka Djurdjev; Mei Chong; Mel Krajden; Monica Beaulieu; Adeera Levin
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

7.  Improving hepatitis B vaccine efficacy in end-stage renal diseases patients and role of adjuvants.

Authors:  Mohammad Hossein Somi; Babak Hajipour
Journal:  ISRN Gastroenterol       Date:  2012-09-18

8.  Epidemiology of hepatitis C virus (HCV) infection.

Authors:  Theodore Sy; M Mazen Jamal
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

9.  Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in ahvaz, southwest iran.

Authors:  Mohammad Ali Assarehzadegan; Mehri Ghafourian Boroujerdnia; Khodamorad Zandian
Journal:  Iran Red Crescent Med J       Date:  2012-08-30       Impact factor: 0.611

10.  Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors.

Authors:  Wiam A Alashek; Christopher W McIntyre; Maarten W Taal
Journal:  BMC Infect Dis       Date:  2012-10-20       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.